Name: Depression and Suicide: Unlocking the Genomic and Transcriptomic Architecture (en Inglés)
Price: 169.97 PEN
Availability: InStock
Author: Emily Chen
ISBN: 9783659770968

portada Depression and Suicide: Unlocking the Genomic and Transcriptomic Architecture (en Inglés)

Depression and Suicide: Unlocking the Genomic and Transcriptomic Architecture (en Inglés)

Formato

Libro Físico

Editorial

Lap Lambert Academic Publishing

Autor

Emily Chen

Idioma

Inglés

N° páginas

112

Encuadernación

Tapa Blanda

ISBN13

9783659770968

Depression and Suicide: Unlocking the Genomic and Transcriptomic Architecture (en Inglés)

Emily Chen (Autor) · Lap Lambert Academic Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 27 días háb.

S/ 377,71S/ 169,97

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

S/ 169,97

Llega entre el 04 Sep y el 14 Sep a CERCADO DE LIMA, Lima. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Depression and Suicide: Unlocking the Genomic and Transcriptomic Architecture (en Inglés)"

Major depressive disorder (MDD) is one of the most challenging psychiatric disorders to study. It is a polygenic disorder that has a lifetime incidence of 10-15%, with women affected twice as often as men, for unknown reasons. The high lifetime prevalence of this non-infectious but debilitating disorder necessitates progress in this field so that better therapeutic drugs can be developed to more effectively treat patients. Genome-wide association studies on major depression have yet to produce significant findings. This is likely because the effects of individual loci are small and/or because the heterogeneity of the disease is high. The involvement of non-genetic factors such as environmental variables is an additional complicating factor. As a result, the deciphering of the genetic architecture is difficult. While both genes and the environment are factors in the development of MDD, this book will focus on the genetics of the disorder. There is an urgent need to understand the genetic basis of MDD and it is our goal to accomplish this by using next-generation sequencing to discover the genomic variants and dysregulated genes that play a role in its development.